THE EVALUATION OF INCREASED SERUM CREATININE DUE TO THE USE OF ACEI THERAPY ON HYPERTENSION PATIENTS IN UNDATA HOSPITAL, PALU, CENTRAL SULAWESI PROVINCE
Objective: This study aims to determine the mean baseline value and the evaluation of serum creatinine in hypertensive patients after receiving angiotensin-converting enzyme inhibitor (ACEi) antihypertensive therapy for the first time in a span.
Methods: This study used a cross-sectional design with a prospective approach by carrying out laboratory tests of serum creatinine using the Jaffe method using the patient’s blood at the beginning as the baseline value and a month after treated with (ACEi) antihypertensive therapy as the evaluation value. The results of this research were analyzed using the SPSS statistical paired test to observe the occurrence of increased serum creatinine as the aftereffect of ACEi antihypertensive treatment. The total of samples which met the inclusion and exclusion criteria was 30 patients.
Results: The findings showed an increase of serum creatinine value, where statistics displayed the significant value of **P below 0.05 with the mean baseline value of 0.98 and an average evaluation value of 1.14. When examined clinically, despite the increase of serum creatinine, the patient’s kidney function is still within a normal range.
Conclusion: The study concluded that the increase of serum creatinine value can become one’s indicators of decreasing kidney function.
2. Ministry of Health. Main Research Results on General Health in the Year of 2018. Indonesia: Ministry of Health; 2018.
3. Dennison-Himmelfarb C, Handler J, Lackland DT. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 2014;311:507-20.
4. Sari YK. The correlation of sexes and hypertention of elderly in nglegok public health centre kabupaten Blitar. J Ners Midwifery 2016;3:262-5.
5. Oktaviarini E, Hadisaputro S, Suwondo A, Setyawan H. High risk factors for hypertension in employees in the area of port perimeter (case control study at semarang Class II port health office). J Health Community Epidemiol 2019;4:35-44.
6. Untari EK, Agilina AR, Susanti R, Studi P, Fakultas F, Universitas K, et al. Evaluation on rationality of hypertension treatment in puskesmas siantan hilir pontianak on 2015. Pharm Sci Res 2018;5:32-9.
7. Nuraini B. Risk factors of hypertension. Artikel Rev 2015;4:10-9. Available from: http://www.juke.kedokteran.unila.ac.id/index.php/ majority/article/view/602/606.
8. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy Handbook. 8th ed., Vol. 8. United States: McGraw-Hill Education; 2015.
9. Sonya AP, Bagus J. A description on the pattern of using antihypertensive medicines in hypertension patients in inpatient installation of Sanglah hospital Denpasar in 2016. J Udayana Med 2019;8:33-7.
10. Wan X, Ma P, Zhang X. A promising choice in hypertension treatment: Fixed-dose combinations. Asian J Pharm Sci 2014;9:1-7.
11. Sun W, Zhang H, Guo J, Zhang X, Zhang L, Li C, et al. Comparison of the efficacy and safety of different ace inhibitors in patients with chronic heart failure. Medicine (United States) 2016;95:1-8.
12. Pascayantri A, Wahyudin E, Farmasi F, Hasanuddin U, Kedokteran F, Hasanuddin U, et al. A study on the use of captopril and Ramipril. Pharm Pharmacol Mag 2018;22:73-5.
13. Siswanto BB, Hersunarti N, Barack R, Lubis RS. Guidelines for managing heart failure. In: Indonesian Cardiologists Association. Indonesia: PERKI; 2015.
14. Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, Sørensen HT, Smeeth L, et al. Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: Cohort study. BMJ 2017;356:1-21.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.